Efficacy News and Research

RSS
PAS announces Cross Marketing agreement with MedLink

PAS announces Cross Marketing agreement with MedLink

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

Research finding may offer future alternative to antibiotics

Research finding may offer future alternative to antibiotics

CSL Behring granted authorization to market Berinert for HAE in Italy and Luxembourg

CSL Behring granted authorization to market Berinert for HAE in Italy and Luxembourg

NOXXON Pharma closes €33 million Series D round of financing

NOXXON Pharma closes €33 million Series D round of financing

YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

Pfizer plans recruitment halt to EMPHASIS-HF trial

Pfizer plans recruitment halt to EMPHASIS-HF trial

Shark cartilage extract shows no benefit for patients with advanced non-small cell lung cancer

Shark cartilage extract shows no benefit for patients with advanced non-small cell lung cancer

Cordis announces launch of ExoSeal Vascular Closure Device

Cordis announces launch of ExoSeal Vascular Closure Device

Wireless monitoring system for people with debilitating conditions

Wireless monitoring system for people with debilitating conditions

Modified measles virus may hold potential for treatment of medulloblastoma

Modified measles virus may hold potential for treatment of medulloblastoma

New study holds promise for patients with LCA

New study holds promise for patients with LCA

Restanza shows greater efficacy against species of Plasmodium that cause malaria

Restanza shows greater efficacy against species of Plasmodium that cause malaria

EMEND indication helps women prevent CINV

EMEND indication helps women prevent CINV

athenahealth releases the fifth annual PayerView Rankings

athenahealth releases the fifth annual PayerView Rankings

Study demonstrates efficacy of CONCERTA in treating ADHD in presence of comorbid learning disability

Study demonstrates efficacy of CONCERTA in treating ADHD in presence of comorbid learning disability

Lyophilized heparin demonstrates better ability to preserve cord blood stem cells than CPD: Study

Lyophilized heparin demonstrates better ability to preserve cord blood stem cells than CPD: Study

RSV appears to be predominant among Kenyan children hospitalized with severe pneumonia: Study

RSV appears to be predominant among Kenyan children hospitalized with severe pneumonia: Study

Positive results from 3 year follow-up of BPH patients treated with NX-1207 in Study NX02-0016

Positive results from 3 year follow-up of BPH patients treated with NX-1207 in Study NX02-0016

Shire announces study results of Vyvanse Capsules CII for treatment of ADHD in adolescents

Shire announces study results of Vyvanse Capsules CII for treatment of ADHD in adolescents

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.